advertisement
Ophthalmology science 114
Showing records 1 to 25 | Display all abstracts in Ophthalmology science108511 Characteristics of a Large, Labeled Data Set for the Training of Artificial Intelligence for Glaucoma Screening with Fundus Photographs
Lemij HG
Ophthalmology science 2023; 3: 100300
108174 Intrasession Repeatability of OCT Angiography Parameters in Neurodegenerative Disease
Akrobetu DY
Ophthalmology science 2023; 3: 100275
108729 Pattern Electroretinogram in Ocular Hypertension, Glaucoma Suspect and Early Manifest Glaucoma Eyes: A Systematic Review and Meta-analysis
Gallo Afflitto G
Ophthalmology science 2023; 3: 100322
108395 Health Disparities in Lapses in Diabetic Retinopathy Care
Cai CX
Ophthalmology science 2023; 3: 100295
108207 Systematic User-centered Design of a Prototype Clinical Decision Support System for Glaucoma
Stagg BC
Ophthalmology science 2023; 3: 100279
108549 Genome-wide Association Studies of Retinal Vessel Tortuosity Identify Numerous Novel Loci Revealing Genes and Pathways Associated With Ocular and Cardiometabolic Diseases
Tomasoni M
Ophthalmology science 2023; 3: 100288
108176 Vitreoretinopathy-Associated Pediatric Retinal Detachment Treatment Outcomes: IRIS® Registry (Intelligent Research in Sight) Analysis
Belin PJ
Ophthalmology science 2023; 3: 100273
108294 No Strong Association between the Apolipoprotein E E4 Allele and Glaucoma: A Multicohort Study
Mullany S
Ophthalmology science 2023; 3: 100287
108603 Association between HSP-Specific T-Cell Counts and Retinal Nerve Fiber Layer Thickness in Patients with Primary Open-Angle Glaucoma
Saini C
Ophthalmology science 2023; 3: 100310
108538 Safety and Target Engagement of Complement C1q Inhibitor ANX007 in Neurodegenerative Eye Disease: Results from Phase I Studies in Glaucoma
Sun Y
Ophthalmology science 2023; 3: 100290
108739 First-in-Human Safety Study of Femtosecond Laser Image-Guided Trabeculotomy for Glaucoma Treatment: 24-month Outcomes
Nagy ZZ
Ophthalmology science 2023; 3: 100313
108604 Phase I NT-501 Ciliary Neurotrophic Factor Implant Trial for Primary Open-Angle Glaucoma: Safety, Neuroprotection, and Neuroenhancement
Goldberg JL
Ophthalmology science 2023; 3: 100298
108176 Vitreoretinopathy-Associated Pediatric Retinal Detachment Treatment Outcomes: IRIS® Registry (Intelligent Research in Sight) Analysis
Naravane AV
Ophthalmology science 2023; 3: 100273
108294 No Strong Association between the Apolipoprotein E E4 Allele and Glaucoma: A Multicohort Study
Diaz-Torres S
Ophthalmology science 2023; 3: 100287
108549 Genome-wide Association Studies of Retinal Vessel Tortuosity Identify Numerous Novel Loci Revealing Genes and Pathways Associated With Ocular and Cardiometabolic Diseases
Beyeler MJ
Ophthalmology science 2023; 3: 100288
108174 Intrasession Repeatability of OCT Angiography Parameters in Neurodegenerative Disease
Robbins CB
Ophthalmology science 2023; 3: 100275
108604 Phase I NT-501 Ciliary Neurotrophic Factor Implant Trial for Primary Open-Angle Glaucoma: Safety, Neuroprotection, and Neuroenhancement
Beykin G
Ophthalmology science 2023; 3: 100298
108729 Pattern Electroretinogram in Ocular Hypertension, Glaucoma Suspect and Early Manifest Glaucoma Eyes: A Systematic Review and Meta-analysis
Chou TH
Ophthalmology science 2023; 3: 100322
108511 Characteristics of a Large, Labeled Data Set for the Training of Artificial Intelligence for Glaucoma Screening with Fundus Photographs
Vente C
Ophthalmology science 2023; 3: 100300
108174 Intrasession Repeatability of OCT Angiography Parameters in Neurodegenerative Disease
Robbins CB
Ophthalmology science 2023; 3: 100275
108739 First-in-Human Safety Study of Femtosecond Laser Image-Guided Trabeculotomy for Glaucoma Treatment: 24-month Outcomes
Kranitz K
Ophthalmology science 2023; 3: 100313
108207 Systematic User-centered Design of a Prototype Clinical Decision Support System for Glaucoma
Tullis B
Ophthalmology science 2023; 3: 100279
108395 Health Disparities in Lapses in Diabetic Retinopathy Care
Tran D
Ophthalmology science 2023; 3: 100295
108603 Association between HSP-Specific T-Cell Counts and Retinal Nerve Fiber Layer Thickness in Patients with Primary Open-Angle Glaucoma
Jiang S
Ophthalmology science 2023; 3: 100310
108538 Safety and Target Engagement of Complement C1q Inhibitor ANX007 in Neurodegenerative Eye Disease: Results from Phase I Studies in Glaucoma
Wirta D
Ophthalmology science 2023; 3: 100290
